Many people living with obesity also develop type 2 diabetes, posing additional health challenges beyond the number on a scale. Our researchers are studying a once-a-day pill to treat obesity that reflects the everyday realities of people living with these chronic diseases. Today we announced more positive late-stage clinical trial results of this potential medicine—putting us one step closer to making an oral option for obesity broadly available if approved by regulators. Read more: https://e.l